NEW YORK - A particularly aggressive form of childhood cancer that forms in muscle tissue might have a new treatment option on the horizon. Scientists have successfully induced rhabdomyosarcoma cells to transform into normal, healthy muscle cells. It's a breakthrough that could see the development of new therapies for the cruel disease, and it could lead
BOSTON - Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development. However, for the vast majority of those mutations, researchers are unsure of how they contribute to cancer because there’s no easy way to study them in animal models. In an advance that could help scientists make a dent in
NEW YORK - In a significant groundbreaking medical development, researchers have created a tiny device, smaller than a grain of rice, to deliver drugs directly to the pancreatic tumor. In the near future, this implantable nanofluidic device could be a game changer in treating pancreatic cancer. Nanomedicine experts at Houston Methodist Academic Institute developed the
LONDON - Artificial intelligence has developed a treatment for an aggressive form of cancer in just 30 days and demonstrated it can predict a patient's survival rate using doctors' notes. The breakthroughs were performed by separate systems, but show how the powerful technology's uses go far beyond the generation of images and text. University of Toronto
LONDON, UK - Scientists have developed a test to identify which blood-cancer patients will benefit the most from a drug that can stop their cancer from returning. The test, which looks for genetic clues in cancer cells, can identify the ten per cent of patients who see little effect from life-saving lenalidomide. This could spare them
KOREA - A simple urine test could soon help prevent pancreatic and prostate cancer from progressing through early detection. Researchers from the Surface & Nano Materials Division of the Korea Institute of Materials Science recently developed a strip-type urine sensor capable of amplifying the light signal of metabolites in urine to diagnose cancer. In a press
DETROIT - Recently, a tiny group of people with rectal cancer saw their disease vanish after experimental treatment. It was a very small trial done by doctors at New York's Memorial Sloan Kettering Cancer Center, wherein the patients took a drug called dostarlimab for six months. At the end of their trial, every single one of their
NEW YORK - In what appears to be a very promising breakthrough for the treatment of rectal cancer, a small drug trial conducted in the US found every patient treated in the experiment had their cancer successfully go into remission. The medication given, called dostarlimab and sold under the brand name Jemperli, is an immunotherapy drug used
DETROIT—Officials at the The Barbara Ann Karmanos Cancer Institute announced that the institute has been awarded a $325,372 grant from U CAN-CER VIVE Foundation. The funds will support cancer research focused on diffuse large B cell lymphoma (DLBCL). “We continue to be amazed by the work the dedicated doctors and researchers at Karmanos have made and are optimistic that this
LANSING - Draft rules for state drinking water standards are expected to be filed ahead of the October 1 timeline to keep on track with having rules put into effect as early as April 2020, members of the Michigan PFAS Action Response Team were told Friday. The draft rules will be submitted in the coming
